In the latest trading session,, 0.45 million Jaguar Health Inc (NASDAQ:JAGX) shares changed hands as the company’s beta touched 0.91. With the company’s most recent per share price at $1.04 changed hands at -$0.05 or -4.13% at last look, the market valuation stands at $9.65M. JAGX’s current price is a discount, trading about -2867.31% off its 52-week high of $30.86. The share price had its 52-week low at $0.90, which suggests the last value was 13.46% up since then. When we look at Jaguar Health Inc’s average trading volume, we note the 10-day average is 0.31 million shares, with the 3-month average coming to 308.86K.
Analysts gave the Jaguar Health Inc (JAGX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended JAGX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Jaguar Health Inc’s EPS for the current quarter is expected to be -2.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Jaguar Health Inc (NASDAQ:JAGX) trade information
Instantly JAGX was in red as seen in intraday trades today. With action -0.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -88.50%, with the 5-day performance at -0.48% in the red. However, in the 30-day time frame, Jaguar Health Inc (NASDAQ:JAGX) is -9.91% down. Looking at the short shares, we see there were 0.33 million shares sold at short interest cover period of 1.12 days.
Jaguar Health Inc (JAGX) estimates and forecasts
Data shows that the Jaguar Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -93.17% over the past 6 months, a 99.28% in annual growth rate that is considerably higher than the industry average of 16.40%. Year-over-year growth is forecast to reach 29.70% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 3.94M. 1 analysts are of the opinion that Jaguar Health Inc’s revenue for the current quarter will be 3.65M. The estimates for the next quarter sales put growth at 58.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 86.10%. The 2024 estimates are for Jaguar Health Inc earnings to increase by 99.27%, but the outlook for the next 5-year period is at 40.00% per year.
JAGX Dividends
Jaguar Health Inc is expected to release its next quarterly earnings report on 2024-Nov-13.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 12.02% of Jaguar Health Inc shares while 1.42% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.62%.
